Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AEJPB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
lN401-20-2
|
|||||
| Synonyms |
LN401-20-2
Click to Show/Hide
|
|||||
| Organization |
LEVENA SUZHOU BIOPHARMA CO LTD
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
5.2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Peripheral myelin protein 22 (Pmp22)
|
Antigen Info | ||||
| Payload Name |
Tubulin inhibitor B
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
CN114106088A+ADC2+Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||